Fear memory recall involves hippocampal somatostatin interneurons.
10.1371/journal.pbio.3002154 · doi-reference
The neural basis of neuropsychiatric symptoms in Alzheimer’s disease.
10.3389/fnagi.2024.1487875 · doi-reference
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies.
10.1038/s41392-024-01911-3 · doi-reference
FSH blockade improves cognition in mice with Alzheimer’s disease.
10.1038/s41586-022-04463-0 · doi-reference
Global burden of Alzheimer’s disease and other dementias in adults aged 65 years and older, 1991-2021: Population-based study.
10.3389/fpubh.2025.1585711 · doi-reference
Sex differences in brain functional connectivity of hippocampus in mild cognitive impairment.
10.3389/fnagi.2022.959394 · doi-reference
CRF and the nucleus incertus: A node for integration of stress signals.
10.1038/nrn.2016.158 · doi-reference
Involvement of relaxin-family peptide-3 receptor (RXFP3) in the ventral dentate gyrus of the hippocampus in spatial and fear memory in rats.
10.1016/j.peptides.2024.171244 · doi-reference
Neuropathology of Alzheimer’s disease.
10.1007/s13311-021-01146-y · doi-reference
Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress.
10.1111/j.1460-9568.2005.03980.x · doi-reference
Brainstem nucleus incertus controls contextual memory formation.
10.1126/science.aaw0445 · doi-reference
Functional neuroanatomy of the rat nucleus incertus-medial septum tract: Implications for the cell-specific control of the septohippocampal pathway.
10.3389/fncel.2022.836116 · doi-reference
Sex differences in Alzheimer’s-related tau biomarkers and a mediating effect of testosterone.
10.1186/s13293-020-00310-x · doi-reference
Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy.
10.1212/wnl.0000000000002570 · doi-reference
Characteristics of cerebrospinal fluid in autism spectrum disorder - A systematic review.
10.1016/j.neubiorev.2025.106202 · doi-reference
The intersection of amyloid beta and tau at synapses in Alzheimer’s disease.
10.1016/j.neuron.2014.05.004 · doi-reference
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
10.1093/brain/awaa327 · doi-reference
Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain.
10.1002/cne.22442 · doi-reference
Relaxin-3 systems in the brain–the first 10 years.
10.1016/j.jchemneu.2011.05.013 · doi-reference
Sex differences in grey matter atrophy patterns among AD and aMCI patients: Results from ADNI.
10.1016/j.neuroimage.2011.02.060 · doi-reference
Neuroprotective role of steroidal sex hormones: An overview.
10.1111/cns.12538 · doi-reference
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The women’s health initiative memory study: A randomized controlled trial.
10.1001/jama.289.20.2651 · doi-reference
Recent advancements in the therapeutic approaches for Alzheimer’s disease treatment: Current and future perspective.
10.1039/d4md00630e · doi-reference
Orienting and reorienting: The locus coeruleus mediates cognition through arousal.
10.1016/j.neuron.2012.09.011 · doi-reference
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
10.18632/oncotarget.5185 · doi-reference
Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: Results from the European prevention of Alzheimer’s disease (EPAD) cohort.
10.1186/s13195-022-01121-5 · doi-reference
Chronic activation of the relaxin-3 receptor on GABA neurons in rat ventral hippocampus promotes anxiety and social avoidance.
10.1002/hipo.23089 · doi-reference
Nucleus incertus–an emerging modulatory role in arousal, stress and memory.
10.1016/j.neubiorev.2011.02.004 · doi-reference
Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat.
10.1016/j.bbr.2013.01.034 · doi-reference
From structure to function: Development of relaxin-3 analogs and their role in RXFP3 signaling.
10.1002/cbic.202500664 · doi-reference
Hippocampus and its involvement in Alzheimer’s disease: A review.
10.1007/s13205-022-03123-4 · doi-reference
Stress activates the nucleus incertus and modulates plasticity in the hippocampo-medial prefrontal cortical pathway.
10.1016/j.brainresbull.2015.10.010 · doi-reference
Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020-2060).
10.1002/alz.12362 · doi-reference
Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer’s disease.
10.1002/alz.71054 · doi-reference
Sex and the development of Alzheimer’s disease.
10.1002/jnr.23827 · doi-reference
Biomarker discovery for disease status and symptom severity in children with autism.
10.1016/j.psyneuen.2017.12.022 · doi-reference
Cytoarchitecture and efferent projections of the nucleus incertus of the rat.
10.1002/cne.10774 · doi-reference
Modulation of forebrain function by nucleus incertus and relaxin-3/RXFP3 signaling.
10.1111/cns.12862 · doi-reference
Nucleus incertus inactivation impairs spatial learning and memory in rats.
10.1016/j.physbeh.2014.11.014 · doi-reference
Mapping cell types and efferent pathways in the ascending relaxin-3 system of the nucleus incertus.
10.1523/eneuro.0272-20.2020 · doi-reference
